Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2015/167064 http://scihub22266oqcxt.onion/10.1155/2015/167064 C4451988!4451988!26090480     free     free     free       J+Immunol+Res 2015 ; 2015 (ä): ä Nephropedia Template TP {{tp|p=26090480|t=2015. Treatment of Bullous Systemic Lupus Erythematosus |pdf=|usr=}}{{26090480}} gab.com Text Treatment of Bullous Systemic Lupus Erythematosus JO: J Immunol Res http://www.kidney.de/pget.php?&tw=1&pmid=26090480 #FOAvip Bullous systemic lupus erythematosus (BSLE) is an autoantibody-mediated vesiculobullous disease in patients with SLE. Autoimmunity in BSLE is characterized by the presence of circulating anti-type VII collagen antibodies. BSLE patients often present with multiple, tense, clear fluid-filled vesicles and bullae overlying erythematous edematous plaques. Skin biopsy from BSLE patients shows subepidermal bullae with numerous neutrophils and only occasional eosinophils. Furthermore, immunofluorescence examination showed linear deposition of lgG, lgA, C3, and C1q along the basement membrane zone. BSLE patients with corticosteroids treatment constantly do not receive a marked improvement, while dapsone generally dramatically improved the skin condition. Recently, it has been reported that quite a few cases of BSLE were successfully treated with other immune suppressive drugs. Therefore, a comprehensive review of the treatment of BSLE would be beneficial to cure the disease. Twit Text FOAVip Treatment of Bullous Systemic Lupus Erythematosus ????J Immunol Res http://www.kidney.de/pget.php?&tw=1&pmid=26090480 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26090480 #FOAvip English Wikipedia <ref>{{Cite pmid|26090480}}</ref> Treatment of Bullous Systemic Lupus Erythematosus #MMPMID26090480 Duan L; Chen L; Zhong S; Wang Y; Huang Y; He Y; Chen J; Shi G J Immunol Res 2015[]; 2015 (ä): ä PMID26090480show ga Bullous systemic lupus erythematosus (BSLE) is an autoantibody-mediated vesiculobullous disease in patients with SLE. Autoimmunity in BSLE is characterized by the presence of circulating anti-type VII collagen antibodies. BSLE patients often present with multiple, tense, clear fluid-filled vesicles and bullae overlying erythematous edematous plaques. Skin biopsy from BSLE patients shows subepidermal bullae with numerous neutrophils and only occasional eosinophils. Furthermore, immunofluorescence examination showed linear deposition of lgG, lgA, C3, and C1q along the basement membrane zone. BSLE patients with corticosteroids treatment constantly do not receive a marked improvement, while dapsone generally dramatically improved the skin condition. Recently, it has been reported that quite a few cases of BSLE were successfully treated with other immune suppressive drugs. Therefore, a comprehensive review of the treatment of BSLE would be beneficial to cure the disease. äTreatment of Bullous Systemic Lupus Erythematosus (epmc).pdf DeepDyve Pubget Overpricing